Key result
Pleconaril is an orally available antipicornaviral agent that shows promising results in treating picornaviral infections, with a safety profile similar to placebo.
Why the study?
Does pleconaril effectively treat picornaviral infections such as respiratory tract infections and meningitis?
Population
Patients with picornaviral infections (rhinoviruses and enteroviruses)
Design
Review
Authors
Loading...
May support pleconaril evaluation for picornaviral infections lacking therapies; leaves open practice change pending RCTs.
Does pleconaril effectively treat picornaviral infections such as respiratory tract infections and meningitis?
Pleconaril is a novel antiviral agent that shows promise for treating picornaviral infections, which currently lack specific antiviral therapies.
Florea et al. (2003) conducted a review in Picornaviral infections. Pleconaril vs. Placebo was evaluated. Pleconaril is an orally available antipicornaviral agent that shows promising results in treating picornaviral infections, with a safety profile similar to placebo.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: